Genovis AB (publ.) (GENO) — Cash Flow Reinvestment Rate
Genovis AB (publ.) (GENO) has a Cash Flow Reinvestment Rate of 1.00x as of December 2025, reinvesting Skr15.90 Million (capex Skr15.90 Million ) from operating cash flow of Skr15.90 Million. Explore GENO capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Genovis AB (publ.) Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Genovis AB (publ.) across 6 annual periods. Also explore Genovis AB (publ.) asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Genovis AB (publ.) (2019–2025)
Year-by-year capital reinvestment analysis for Genovis AB (publ.). For live market cap and broader valuation context, see Genovis AB (publ.) stock valuation.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | Skr32.02 Million | Skr32.02 Million | Skr32.02 Million | ▲ +139.3% |
| 2024 | 0.42x | Skr15.51 Million | Skr37.12 Million | Skr1.09 Million | ▼ -47.5% |
| 2023 | 0.80x | Skr53.94 Million | Skr67.75 Million | Skr12.81 Million | ▲ +493.8% |
| 2021 | 0.13x | Skr6.16 Million | Skr45.92 Million | Skr4.49 Million | ▼ -97.7% |
| 2020 | 5.88x | Skr22.10 Million | Skr3.76 Million | Skr20.43 Million | ▲ +1032.5% |
| 2019 | 0.52x | Skr6.82 Million | Skr13.13 Million | Skr5.15 Million | — |